Peapack-Gladstone Financial Corp’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $568K | Hold |
6,853
| – | – | 0.01% | 463 |
|
|
2025
Q1 | $556K | Sell |
6,853
-375
| -5% | -$30.4K | 0.01% | 467 |
|
|
2024
Q4 | $651K | Sell |
7,228
-2,135
| -23% | -$192K | 0.01% | 439 |
|
|
2024
Q3 | $925K | Sell |
9,363
-727
| -7% | -$71.8K | 0.01% | 402 |
|
|
2024
Q2 | $935K | Sell |
10,090
-880
| -8% | -$81.5K | 0.01% | 403 |
|
|
2024
Q1 | $1.04M | Sell |
10,970
-645
| -6% | -$61.2K | 0.02% | 391 |
|
|
2023
Q4 | $1.04M | Sell |
11,615
-1,150
| -9% | -$103K | 0.02% | 388 |
|
|
2023
Q3 | $932K | Sell |
12,765
-360
| -3% | -$26.3K | 0.02% | 393 |
|
|
2023
Q2 | $1.09M | Sell |
13,125
-680
| -5% | -$56.6K | 0.02% | 380 |
|
|
2023
Q1 | $1.14M | Buy |
13,805
+340
| +3% | +$28.2K | 0.02% | 368 |
|
|
2022
Q4 | $1.12M | Sell |
13,465
-292
| -2% | -$24.2K | 0.02% | 354 |
|
|
2022
Q3 | $1.09M | Buy |
+13,757
| New | +$1.09M | 0.02% | 357 |
|